Section one: Contracting authority
one.1) Name and addresses
Newcastle University
Newcastle University, Procurement Services, Kingsgate
Newcastle
NE1 7RU
Contact
Mrs Natalie Morton
Telephone
+44 1912086396
Country
United Kingdom
Region code
UKC - North East (England)
Internet address(es)
Main address
Buyer's address
one.1) Name and addresses
Durham University
The Palatine Centre, Stockton Road
Country
United Kingdom
Region code
UKC - North East (England)
Internet address(es)
Main address
one.1) Name and addresses
Northumbria University Newcastle Newcastle
Newcastle upon Tyne
Country
United Kingdom
Region code
UKC - North East (England)
Internet address(es)
Main address
one.1) Name and addresses
University of Sunderland
Sunderland
Cheryl.Holmstrom@sunderland.ac.uk
Country
United Kingdom
Region code
UKC - North East (England)
Internet address(es)
Main address
one.1) Name and addresses
Teesside University
Middlesbrough, Tees Valley
Country
United Kingdom
Region code
UKC - North East (England)
Internet address(es)
Main address
one.1) Name and addresses
University of Bath on behalf of the SETsquared
Claverton Down, Bath
Country
United Kingdom
Region code
UK - United Kingdom
Internet address(es)
Main address
one.2) Information about joint procurement
The contract involves joint procurement
The contract is awarded by a central purchasing body
one.4) Type of the contracting authority
Body governed by public law
one.5) Main activity
Education
Section two: Object
two.1) Scope of the procurement
two.1.1) Title
(NU/1433-36) IndigoDX Ltd: Commercialisation of university research through provision of management skills to assist in successful spin-out company creation
Reference number
DN621227
two.1.2) Main CPV code
- 79400000 - Business and management consultancy and related services
two.1.3) Type of contract
Services
two.1.4) Short description
1 in 5 adults in the UK suffer from urinary symptoms caused by an overactive bladder (OAB). Symptoms include urgency (a sudden compelling desire to pass urine, which cannot be deferred), increased frequency of voiding (both day and night) and urge incontinence (involuntary leakage accompanied by / immediately preceded by urgency).
The Team wishes to establish a spinout company to produce a Dipstick-style test. Our discovery is currently being developed into a simple-to-use diagnostic tool used for (1) regular screening for OAB in adults, at a GP surgery, pharmacy or nursing home, and (2) to assess the effectiveness of treatments (companion diagnostic) and modifying dosing/treatments accordingly. Accurate and early diagnosis will improve treatment outcomes, eliminating the need for patients to have invasive and high-risk surgery-led second-line treatments necessary for advanced-stage disease.
Currently there is no competition for a non-invasive biomarker-based test, and new product development activity appears to be very limited, suggesting an opportunity for ‘first mover advantage’ and to establish a standard.
We require a driven executive to take this technology forward and build a compelling proposition for investment. The Executive will need to create a robust business model that is acceptable to the founders, develop and deliver pitch materials for investors and establish collaborative research projects.
The executive appointed should have an appropriate background, ideally with experience of high tech starts ups, securing seed investment and establishing manufacturing facilities.
two.1.6) Information about lots
This contract is divided into lots: No
two.1.7) Total value of the procurement (excluding VAT)
Value excluding VAT: £30,000
two.2) Description
two.2.3) Place of performance
NUTS codes
- UKC - North East (England)
two.2.4) Description of the procurement
1 in 5 adults in the UK suffer from urinary symptoms caused by an overactive bladder (OAB). Symptoms include urgency (a sudden compelling desire to pass urine, which cannot be deferred), increased frequency of voiding (both day and night) and urge incontinence (involuntary leakage accompanied by / immediately preceded by urgency).
The Team wishes to establish a spinout company to produce a Dipstick-style test. Our discovery is currently being developed into a simple-to-use diagnostic tool used for (1) regular screening for OAB in adults, at a GP surgery, pharmacy or nursing home, and (2) to assess the effectiveness of treatments (companion diagnostic) and modifying dosing/treatments accordingly. Accurate and early diagnosis will improve treatment outcomes, eliminating the need for patients to have invasive and high-risk surgery-led second-line treatments necessary for advanced-stage disease.
Currently there is no competition for a non-invasive biomarker-based test, and new product development activity appears to be very limited, suggesting an opportunity for ‘first mover advantage’ and to establish a standard.
We require a driven executive to take this technology forward and build a compelling proposition for investment. The Executive will need to create a robust business model that is acceptable to the founders, develop and deliver pitch materials for investors and establish collaborative research projects.
The executive appointed should have an appropriate background, ideally with experience of high tech starts ups, securing seed investment and establishing manufacturing facilities.
two.2.5) Award criteria
Quality criterion - Name: Ability to meet the required programme / Weighting: Pass / Fail
Quality criterion - Name: Confirm acceptance of the formal appointment to the board milestone requirements / Weighting: Pass / Fail
Quality criterion - Name: Quality: Ability to meet the Job Description required for the individual / Weighting: 70
Quality criterion - Name: Equity share / Weighting: 5
Price - Weighting: 25
two.2.11) Information about options
Options: No
two.2.13) Information about European Union Funds
The procurement is related to a project and/or programme financed by European Union funds: Yes
Identification of the project
Northern Accelerator programme involving funding from both the European Regional Development Funding (ERDF) and Research England
Section four. Procedure
four.1) Description
four.1.1) Type of procedure
Restricted procedure
four.1.3) Information about a framework agreement or a dynamic purchasing system
The procurement involves the setting up of a dynamic purchasing system
four.1.8) Information about the Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement: No
four.2) Administrative information
four.2.1) Previous publication concerning this procedure
Notice number: 2022/S 186-528050
Section five. Award of contract
A contract/lot is awarded: Yes
five.2) Award of contract
five.2.1) Date of conclusion of the contract
6 September 2022
five.2.2) Information about tenders
Number of tenders received: 1
Number of tenders received from SMEs: 1
Number of tenders received from tenderers from other EU Member States: 0
Number of tenders received from tenderers from non-EU Member States: 1
Number of tenders received by electronic means: 1
The contract has been awarded to a group of economic operators: No
five.2.3) Name and address of the contractor
DU Biosciences
London
SW19 1JG
Country
United Kingdom
NUTS code
- UKC - North East (England)
The contractor is an SME
Yes
five.2.4) Information on value of contract/lot (excluding VAT)
Total value of the contract/lot: £30,000
Section six. Complementary information
six.4) Procedures for review
six.4.1) Review body
Newcastle University
Tyne and Wear
NE1 7RU
Country
United Kingdom
six.4.2) Body responsible for mediation procedures
Newcastle University
Tyne and Wear
Country
United Kingdom
six.4.3) Review procedure
Precise information on deadline(s) for review procedures
The University will incorporate a standstill period at the point information on the award of the
contract is communicated to tenderers. That notification will provide full information on the
award decision. The standstill period, which will be for a minimum of 10 calendar days,
provides time for unsuccessful tenderers to challenge the award decision before the
contract is entered into.
The Public Contracts Regulations 2015 (SI 2015 No 102) provide for aggrieved parties who
have been harmed or are at risk of harm by a breach of the rules to take action in the High
Court (England, Wales and Northern Ireland) within 30 days of knowledge or constructive
knowledge of breach.
six.4.4) Service from which information about the review procedure may be obtained
Newcastle University
Tyne and Wear
Country
United Kingdom